Cytogenetic and fluorescence in situ hybridization analyses of a microcystic adnexal carcinoma with del(6)(q23q25)

Cancer Genetics and Cytogenetics

Volumn 98, Issue 2, 1997, Pages 106-110

  Wohlfahrt, Caspar ^a,b   Ternesten, Annika ^a   Sahlin, Pelle ^a   Islam, Quamrul ^b   Stenman, Göran ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 6Q; CHROMOSOME DELETION; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; KARYOTYPE; PRIORITY JOURNAL; SWEAT GLAND CARCINOMA;

CARCINOMA, SKIN APPENDAGE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MIDDLE AGED; SKIN DISEASES; SKIN NEOPLASMS;

MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0030954787     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00417-7     Document Type: Article

References (22)

1. Goldstein DJ, Barr RJ, Santa Cruz DJ (1982): Microcystic adnexal carcinoma: a distinct clinicopathologic entity. Cancer 50:566-572.
2. Glatt HJ, Proia AD, Tsoy EA, Fetter BF, Klintworth GK, Neuhaus SR, Font RL (1984): Malignant syringoma of the eyelid. Ophthalmology 91:987-990.
3. Cooper PH, Mills SE, Leonard DD, Santa Cruz DJ, Headington JT, Barr RJ, Katz DA (1985): Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol 9:422-433.
4. Apisarnthanarax P, Bovenmyer DA, Mehregan AH (1984): Combined adnexal tumor of the skin. Arch Dermatol 120: 231-233.
5. Chow WC, Cockerell CJ, Geronemus RG (1989): Microcystic adnexal carcinoma of the scalp. J Dermatol Surg Oncol 15: 768-771.
6. Nickoloff BJ, Fleischmann HE, Carmel J, Wood CC, Roth RJ (1986): Microcystic adnexal carcinoma: immunohistologic observations suggesting dual (pilar and eccrine) differentiation. Arch Dermatol 122:290-294.
7. Kato H, Mizuno N, Nakagawa K, Furukawa M, Hamada T (1990): Microcystic adnexal carcinoma: a light microscopic, immunohistochemical and ultrastructural study. J Cutan Pathol 17:87-95.
8. Hsu SM, Raine L, Fanger H (1981): Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
9. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
10. Sandros J, Stenman G, Mark J (1990): Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet 44:153-167.
11. Nordkvist A (1993): Genetic alterations in salivary gland tumors. Thesis, Gothenburg University, Sweden.
12. Jin Y, Mertens F, Limon J, Mandahl N, Wennerberg J, Dictor M, Heim S, Mitelman F (1994): Characteristic karyotypic features in lacrimal and salivary gland carcinomas. Br J Cancer 70:42-47.
13. Jin Y, Mertens F, Mandahl N, Heim S, Olegård C, Wennerberg J, Biörklund A, Mitelman F (1993): Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: influence of culture conditions on karyotypic pattern. Cancer Res 53:2140-2146.
14. Nordkvist A, Edström S, Mark J, Stenman G (1992): Multiple unrelated chromosome abnormalities in a metastatic mucoepidermoid carcinoma of the parotid gland. Cancer Genet Cytogenet 61:158-161.
15. Mark J, Sandras J, Wedell B, Stenman G, Ekedahl C (1988): Significance of the choice of tissue culture technique on the chromosomal patterns in human mixed salivary gland tumors. Cancer Genet Cytogenet 33:229-244.
16. Mark J, Ekedahl C (1987): Polyclonal chromosomal evolution in a benign salivary gland tumor. Cancer Genet CytogenJet 28: 237-243.
17. Mark J, Dahlenfors R, Wedell B (1996): Is pleomorphic adenoma of the salivary glands a tumor of congenital or very early origin? Evidence from cytogenetical observations in two cases. Oncol Reports 3:1075-1077.
18. Hasebe T, Mukai K, Yamaguchi N, Ishihara K, Kaneko A, Takasaki Y, Shimosato Y (1994): Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parmeters. Modern Pathol 7:37-43.
19. Slamon DJ, Press MF, Godolphin W, Ramos L, Haran P, Shek L, Stuart SG, Ullrich A (1989): Studies of the HER-2/neu protooncogene in human breast cancer. Cancer Cells 7:371-384.
20. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989): Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 244:707-712.
21. Stenman G, Sandros J, Nordkvist A, Mark J, Sahlin P (1991): Expression of the ERBB2 protein in benign and malignant salivary gland tumors. Genes Chromosom Cancer 3:128-135.
22. Dijkhuizen T, van den Berg E, Nikkels PGJ, Hoekstra HJ, de Jong B (1992): Cytogenetics of a case of eccrine spiradenoma. Human Pathol 23:1085-1087.